Table 2.

Logistic regression modelling for evaluation of the associations with the outcome in the population

	HR	95% C.I	p value
High-risk Patients	2.25	1.04–4.86	0.039
Ln (IGF-1)	0.42	0.23–0.77	0.005
HF etiology
Idiopathic	Ref.
Ischemic	1.63	0.73–3.63	0.23
Valvular	5.85	2.02–16.94	0.001
CKD-EPI stage
I–II	Ref.
III	1.63	0.73–3.63	0.16
IV–V	4.86	1.48–15.95	0.009

HR Hazard Ratio, C.I. Confidential Interval, IGF-1 Insuline-like Growth Factor-1, HF Heart Failure